These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3666042)

  • 1. Dissociation of actions of BRL 34915 in the rat portal vein.
    Shetty SS; Weiss GB
    Eur J Pharmacol; 1987 Sep; 141(3):485-8. PubMed ID: 3666042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein.
    Hamilton TC; Weir SW; Weston AH
    Br J Pharmacol; 1986 May; 88(1):103-11. PubMed ID: 3708211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effluxes of 42K+ and 86Rb+ elicited by cromakalim (BRL 34915) in tonic and phasic vascular tissue.
    Quast U; Baumlin Y
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):319-26. PubMed ID: 3194039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of putative K+ channel activator BRL-34915 on arterial contraction and 86Rb efflux.
    Cox RH
    J Pharmacol Exp Ther; 1990 Jan; 252(1):51-9. PubMed ID: 2299602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels.
    Weir SW; Weston AH
    Br J Pharmacol; 1986 May; 88(1):121-8. PubMed ID: 2423172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRL 34915 (Cromakalim) stimulation of 42K efflux from rabbit arteries is modulated by calcium.
    Post JM; Smith JM; Jones AW
    J Pharmacol Exp Ther; 1989 Aug; 250(2):591-7. PubMed ID: 2760842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the K+ efflux stimulating vasodilator BRL 34915 on 86Rb+ efflux and spontaneous activity in guinea-pig portal vein.
    Quast U
    Br J Pharmacol; 1987 Jul; 91(3):569-78. PubMed ID: 3038244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.
    Winquist RJ; Heaney LA; Wallace AA; Baskin EP; Stein RB; Garcia ML; Kaczorowski GJ
    J Pharmacol Exp Ther; 1989 Jan; 248(1):149-56. PubMed ID: 2464055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim.
    Newgreen DT; Bray KM; McHarg AD; Weston AH; Duty S; Brown BS; Kay PB; Edwards G; Longmore J; Southerton JS
    Br J Pharmacol; 1990 Jul; 100(3):605-13. PubMed ID: 2167738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of potassium channels in the action of ciclazindol in rat portal vein.
    Noack T; Edwards G; Deitmer P; Greengrass P; Morita T; Andersson PO; Criddle D; Wyllie MG; Weston AH
    Br J Pharmacol; 1992 May; 106(1):17-24. PubMed ID: 1504725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of racemic cromakalim, BRL 38226 and levcromakalim on the membrane potential of the rat aorta and of BRL 38226 on the contractile activity of the rat aorta and portal vein.
    Bishop BE; Doggrell SA
    J Auton Pharmacol; 1994 Apr; 14(2):99-108. PubMed ID: 8051202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.
    Perez-Vizcaino F; Casis O; Rodriguez R; Gomez LA; Garcia Rafanell J; Tamargo J
    Br J Pharmacol; 1993 Nov; 110(3):1165-71. PubMed ID: 8298804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of BRL 34915, a putative K channel opener, on transmembrane 45Ca movements in rabbit aortic smooth muscle.
    Chiu PJ; Tetzloff G; Ahn HS; Sybertz EJ
    Eur J Pharmacol; 1988 Oct; 155(3):229-37. PubMed ID: 3234486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the relaxing effects of cicletanine and cromakalim on vascular smooth muscle.
    Deitmer P; Golenhofen K; Noack T
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):35-42. PubMed ID: 1383629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein.
    Hu SL; Kim HS; Okolie P; Weiss GB
    J Pharmacol Exp Ther; 1990 May; 253(2):771-7. PubMed ID: 2110977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activator. Comparison with nicorandil.
    Coldwell MC; Howlett DR
    Biochem Pharmacol; 1987 Nov; 36(21):3663-9. PubMed ID: 2445348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915.
    Cook NS; Quast U; Hof RP; Baumlin Y; Pally C
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):90-9. PubMed ID: 2450263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium channel opening properties of a novel compound, NIP-121, cromakalim and nicorandil in rat aorta and portal vein.
    Masuda Y; Arakawa C; Yamashita T; Miyajima M; Shigenobu K; Kasuya Y; Tanaka S
    Eur J Pharmacol; 1991 Apr; 195(3):323-31. PubMed ID: 1831135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leiurus quinquestriatus venom inhibits BRL 34915-induced 86Rb+ efflux from the rat portal vein.
    Quast U; Cook NS
    Life Sci; 1988; 42(7):805-10. PubMed ID: 2448575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of several potassium-channel openers on rat bladder and rat portal vein in vitro.
    Edwards G; Henshaw M; Miller M; Weston AH
    Br J Pharmacol; 1991 Mar; 102(3):679-86. PubMed ID: 1364839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.